Advisory Board May 26, 2020

People worldwide are anxiously awaiting the creation of an effective vaccine for the new coronavirus, which is being touted as a beacon of hope for ending the Covid-19 pandemic. But experts say the public should be measured in their expectations for the vaccine—and shouldn’t expect it to eradicate the virus entirely.

Will we really have a coronavirus vaccine in 12 to 18 months?

Vaccines can have setbacks

For one, experts note that new vaccine candidates can face setbacks in both safety and efficacy—and the risks of those setbacks can increase when development of a vaccine is rushed.

For example, in 1976, the United States rushed development and approval of a vaccine in response to fears of a swine flu...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing
ETH develops AI algorithm for drug discovery based on 3D protein surface

Share This Article